Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

Abstract

ObjectiveEvaluate golimumab in patients with active rheumatoid arthritis (RA) and previous tumour necrosis factor-α (TNF) inhibitor use.MethodsPatients (n=461) previously receiving ≥1 TNF inhibitor were randomised to subcutaneous injections of placebo,...